Cronos Group Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Cannabis Flower at $108.5 million, 74% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
|---|---|---|---|---|---|---|---|---|
| Revenue |
206
|
147
|
118
|
87
|
87
|
65
|
47
|
24
|
| Cannabis Flower |
155
+57.6%
share 75.0%
|
108
+23.4%
share 74.0%
|
88
+41.6%
share 74.7%
|
62
-2.4%
share 71.1%
|
64
+15.2%
share 73.3%
|
55
+97.6%
share 85.5%
|
28
+86.0%
share 59.8%
|
15
share 63.2%
|
| Cannabis Extracts |
51
+53.5%
share 25.0%
|
38
+29.3%
share 25.7%
|
29
+18.7%
share 24.8%
|
25
+9.1%
share 28.2%
|
23
+155.7%
share 26.0%
|
9
-51.8%
share 13.6%
|
18
+109.8%
share 39.1%
|
9
share 36.6%
|
| Product And Service Other |
0
-90.7%
share 0.0%
|
0
-23.2%
share 0.3%
|
1
-11.1%
share 0.5%
|
1
-5.0%
share 0.7%
|
1
+13.2%
share 0.7%
|
1
+5.1%
share 0.9%
|
1
+1803.6%
share 1.1%
|
0
share 0.1%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CRON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Stayner, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1656472
- Former names
- PharmaCan Capital Corp. (until May 27, 2016)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.